Omewon Capsule (Omeprazole)
Omeprazole Enteric Coated Granules 233mg
Hard capsule · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.
MFDS item code 202002144 · Approved 2020.03.27
This product's status changed to Expired on 2025.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment and prevention of gastroesophageal reflux disease, gastrointestinal disorders (ulcers, etc.), and Zollinger-Ellison syndrome
This medication is used for the short-term treatment of gastric ulcers and duodenal ulcers. It also treats symptoms such as heartburn and regurgitation caused by gastroesophageal reflux disease (GERD). It is effective in Zollinger-Ellison syndrome and is used in maintenance therapy for severe gastroesophageal reflux disease and difficult-to-treat peptic ulcers. It is used in combination with antibiotics to prevent recurrence of duodenal ulcers caused by Helicobacter pylori infection and helps in the treatment of gastric and duodenal ulcers and erosion caused by non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, it is used to prevent gastric and duodenal ulcers and dyspepsia symptoms in patients receiving long-term NSAID therapy, as well as to prevent recurrence of gastroesophageal reflux disease. This medication is effectively used to treat various symptoms and lesions related to gastrointestinal disorders.
1. Adults 1) Gastric ulcer: Administer omeprazole 20mg orally once daily. Most ulcers may heal within 4 weeks, although healing time may vary in some patients. If the ulcer has not healed after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other agents, a dose of 40mg once daily usually results in healing within 8 weeks, although healing time may vary in some patients. Repeat treatment if the ulcer recurs. 2) Short-term treatment of duodenal ulcers: Administer 20mg orally once daily. Most ulcers may heal within 2 weeks, although healing time may vary in some patients. If the ulcer has not healed after the initial 2 weeks of treatment, continue treatment for an additional 2 weeks. In patients who have not responded to other agents, a dose of 40mg once daily usually results in healing within 4 weeks, although healing time may vary in some patients. Repeat treatment if the ulcer recurs. 3) Reflux esophagitis: Administer 20mg orally once daily. Most cases may heal within 4 weeks, although healing time may vary in some patients. If the condition has not healed after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. In patients who have not responded to other agents, a dose of 40mg once daily usually results in healing within 8 weeks, although healing time may vary in some patients. Repeat treatment if the condition recurs. 4) Zollinger-Ellison syndrome: The initial dose is 60mg orally once daily. Continue treatment with the dose adjusted appropriately for each individual. More than 90% of patients respond to doses of 20 - 120mg per day. If administering more than 80mg per day, divide the dose into 2 administrations per day. 5) Maintenance therapy for severe reflux esophagitis and peptic ulcers that are difficult to treat: Administer 20mg orally once daily. If the condition recurs, the dose may be increased to 40mg once daily. 6) Antibiotic combination therapy to prevent recurrence of duodenal ulcers infected with Helicobacter pylori: - Dual therapy: Administer this drug 20mg and amoxicillin 750 - 1000mg twice daily for 2 weeks. - Triple therapy: Administer this drug 40mg once daily or 20mg twice daily in combination with the following antibiotics. ① Administer clarithromycin 250mg and metronidazole 400mg twice daily for 1 week, or ② Administer amoxicillin 1g and clarithromycin 500mg twice daily for 1 week. If the treatment effect is insufficient, omeprazole monotherapy may be continued. 7) Treatment of symptoms of gastroesophageal reflux disease (GERD) (heartburn, regurgitation, etc.): Administer 20mg orally once daily. Healing is generally possible with 2-4 weeks of treatment. 8) Treatment of gastric or duodenal ulcers or erosions caused by nonsteroidal anti-inflammatory drugs (NSAIDs): Administer 20mg orally once daily. Most cases may heal within 4 weeks, although healing time may vary in some patients. If the condition has not healed after the initial 4 weeks of treatment, continue treatment for an additional 4 weeks. 9) Maintenance therapy for prevention of gastric or duodenal ulcers or erosions and dyspeptic symptoms caused by NSAID use in patients receiving long-term NSAID treatment who have a history of gastric or duodenal lesions: Administer 20mg orally once daily. * Take this drug whole with at least half a glass of water. Adjust the dose as appropriate according to age and symptoms.
This medication should not be administered to specific patients. For example, individuals allergic to the drug's components should not use it. Additionally, caution is needed when administering this medication to gastric ulcer patients suspected of malignant tumors, as symptom relief may delay diagnosis. Patients taking other medications that interact with this medication should also avoid use, especially those taking drugs containing atazanavir or rilpivirine. Patients with genetic lactose intolerance may experience side effects due to lactose contained in this medication, so they should not use it. Patients with impaired liver function may have increased drug levels in their bodies, so dosage should be reduced and administered cautiously, particularly patients with severe liver impairment should not exceed 20mg per day. Caution is also necessary for older adults using this medication. This medication may cause neurological side effects such as headaches, dizziness, and drowsiness, and liver enzyme levels may increase, so treatment should be discontinued if abnormal signs occur. Common gastrointestinal side effects may include diarrhea, nausea, and abdominal pain, as well as reported allergic reactions such as skin rash or itching. In severe cases, various side effects may occur, including anaphylactic shock, cardiovascular abnormalities, blood cell reductions, muscle pain, and hair loss. Long-term use may increase the risk of fractures and electrolyte imbalances such as hypomagnesemia, requiring regular monitoring. This medication may slightly increase the risk of bacterial infections in the stomach by inhibiting gastric acid secretion, so if diarrhea persists, consult a physician. Women who are pregnant or may become pregnant should only use this medication if absolutely necessary, as it may affect the fetus. Nursing mothers should avoid this medication or discontinue breastfeeding as it may pass into breast milk. Safety in children has not been sufficiently established, so caution is needed when using it. In case of overdose, symptoms such as vomiting, diarrhea, headache, and confusion may appear, but most are transient. This medication should be kept out of the reach of children and stored with the cap tightly closed in the original container, not transferred to other containers. Long-term use of this medication may lead to hypertrophy of certain gastric cells or increase the risk of gastric cancer, so it is crucial to use the minimum effective dose and duration under a physician's guidance.
Headache, drowsiness, dizziness, insomnia, paresthesia, feeling faint, vertigo, confusion, excitation, aggressiveness, hallucination, depression, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, interstitial nephritis, diarrhea, weight loss, constipation, nausea, vomiting, abdominal pain, abdominal distension, dry mouth, stomatitis, gastrointestinal candidiasis, erythema, rash, urticaria, itching, dermatitis, vesicular rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, photosensitivity, alopecia, angioedema, fever, bronchospasm, interstitial nephritis, anaphylactic shock, chest pain, tachycardia, bradycardia, palpitations, leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, back pain, arthralgia, muscle weakness, myalgia, gynecomastia, cough, asthenia, fatigue, peripheral edema, increased sweating, blurred vision, visual impairment, taste disturbance, breast pain in women, breast lump, hyponatremia, erectile dysfunction, Clostridium difficile-associated diarrhea, hypomagnesemia, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, systemic lupus erythematosus, discoid lupus erythematosus, gastric polyps, hypocalcemia, hypokalemia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature to ensure the longevity of the medication's effectiveness and safety.
A hard capsule with an upper reddish-brown part and a lower pink part filled with light yellow enteric-coated granules.
28 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Omeprazole Enteric Coated Granules 233mg
Hard capsule · Prescription medication
Wonkwang Pharmaceutical Co., Ltd.

Omeprazole Enteric Coated Granules 230mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Omeprazole Enteric Coated Granules 230mg
Hard capsule · Prescription medication
Aju Pharmaceutical Co., Ltd.
Omeprazole Enteric Coated Granules 232.6mg
Hard capsule · Prescription medication
Hana Pharmaceutical Co., Ltd.
Omeprazole Enteric Coated Granules 230mg
Prescription medication
Shinil Pharmaceutical Co., Ltd.

Omeprazole Enteric Coated Granules 233mg
Hard capsule · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
Omeprazole Enteric Coated Granules 230mg
Prescription medication
Hanol BioPharma Co., Ltd.

Omeprazole Enteric Coated Granules 230mg
Hard capsule · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.